411 filings
8-K
QNRX
Quoin Pharmaceuticals Ltd
9 Apr 24
Submission of Matters to a Vote of Security Holders
4:05pm
EFFECT
QNRX
Quoin Pharmaceuticals Ltd
4 Apr 24
Notice of effectiveness
12:15am
DEFA14A
QNRX
Quoin Pharmaceuticals Ltd
2 Apr 24
Additional proxy soliciting materials
11:04am
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
10-K
2023 FY
QNRX
Quoin Pharmaceuticals Ltd
Annual report
14 Mar 24
4:42pm
8-K
QNRX
Quoin Pharmaceuticals Ltd
13 Mar 24
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
4:52pm
424B3
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Prospectus supplement
4:06pm
424B3
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Prospectus supplement
4:04pm
8-K
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
424B4
QNRX
Quoin Pharmaceuticals Ltd
6 Mar 24
Prospectus supplement with pricing info
5:07pm
8-K
QNRX
Quoin Pharmaceuticals Ltd
6 Mar 24
Other Events
4:01pm
424B3
QNRX
Quoin Pharmaceuticals Ltd
4 Mar 24
Prospectus supplement
5:27pm
DEF 14A
QNRX
Quoin Pharmaceuticals Ltd
Definitive proxy
27 Feb 24
6:01am
EFFECT
QNRX
Quoin Pharmaceuticals Ltd
15 Feb 24
Notice of effectiveness
12:15am
CORRESP
QNRX
Quoin Pharmaceuticals Ltd
14 Feb 24
Correspondence with SEC
12:00am
CORRESP
QNRX
Quoin Pharmaceuticals Ltd
14 Feb 24
Correspondence with SEC
12:00am
SC 13G/A
Lind Global Fund II LP
13 Feb 24
Quoin Pharmaceuticals / Lind Global Fund II ownership change
8:11pm
S-1/A
QNRX
Quoin Pharmaceuticals Ltd
IPO registration (amended)
13 Feb 24
4:50pm
PRE 14A
QNRX
Quoin Pharmaceuticals Ltd
Preliminary proxy
13 Feb 24
4:30pm
UPLOAD
QNRX
Quoin Pharmaceuticals Ltd
13 Feb 24
Letter from SEC
12:00am